Related references
Note: Only part of the references are listed.Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial
Anahita Rouze et al.
INTENSIVE CARE MEDICINE (2017)
Epidemiology of Hospitalizations Associated with Invasive Candidiasis, United States, 2002-2012
Sara Strollo et al.
EMERGING INFECTIOUS DISEASES (2017)
Plasma presepsin level is an early diagnostic marker of severe febrile neutropenia in hematologic malignancy patients
Yusuke Koizumi et al.
BMC INFECTIOUS DISEASES (2017)
Diagnostic value of levels of presepsin (soluble CD14-subtype) in febrile neutropenia in patients with hematological disorders
Hideo Koh et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2016)
Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment
M. Carmen Martinez-Jimenez et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Phagocytosis by human monocytes is required for the secretion of presepsin
Yasuyuki Arai et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2015)
Invasive Candidiasis
Bart Jan Kullberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Clinical Impact of Kidney Function on Presepsin Levels
Takanobu Nagata et al.
PLOS ONE (2015)
The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort Studies
Tie-Ying Hou et al.
PLOS ONE (2015)
The accuracy of presepsin (sCD14-ST) for the diagnosis of sepsis in adults: a meta-analysis
Xin Zhang et al.
CRITICAL CARE (2015)
Presepsin (sCD14-ST) in emergency department: The need for adapted threshold values?
Camille Chenevier-Gobeaux et al.
CLINICA CHIMICA ACTA (2014)
What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients
Cristobal Leon et al.
INTENSIVE CARE MEDICINE (2014)
Multistate Point- Prevalence Survey of Health Care- Associated Infections
Shelley S. Magill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Presepsin (soluble CD14 subtype) and procalcitonin levels for mortality prediction in sepsis: data from the Albumin Italian Outcome Sepsis trial
Serge Masson et al.
CRITICAL CARE (2014)
Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis
Christina Wacker et al.
LANCET INFECTIOUS DISEASES (2013)
Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20-year autopsy study
Russell E. Lewis et al.
MYCOSES (2013)
Diagnostic value and prognostic evaluation of Presepsin for sepsis in an emergency department
Bo Liu et al.
CRITICAL CARE (2013)
Septic Shock Attributed to Candida Infection: Importance of Empiric Therapy and Source Control
Marin Kollef et al.
CLINICAL INFECTIOUS DISEASES (2012)
Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions
Cristobal Leon et al.
INTENSIVE CARE MEDICINE (2012)
Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study
Shigeatsu Endo et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia
Malgorzata Mikulska et al.
CRITICAL CARE (2010)
Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients
Pierre Emmanuel Charles et al.
INTENSIVE CARE MEDICINE (2006)
Delaying the empiric treatment of Candida bloodstream infection until positive blood culture results are obtained:: a potential risk factor for hospital mortality
M Morrell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Emerging trends in the epidemiology of invasive mycoses in England and Wales (1990-9)
TL Lamagni et al.
EPIDEMIOLOGY AND INFECTION (2001)
Share Paper
